Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy.
Fiche publication
Date publication
juillet 2018
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NOEL Georges
Tous les auteurs :
Weber DC, Murray F, Combescure C, Calugaru V, Alapetite C, Albertini F, Bolle S, Goudjil F, Pica A, Walser M, Mammar H, Bachtiary B, Lomax T, Noël G, Dendale R, Feuvret L
Lien Pubmed
Résumé
Skull-base chondrosarcoma (ChSa) is a rare bone tumor and the outcome of patients with this malignancy has been documented only in a limited number of series with a restricted number of patients.
Mots clés
Chondrosarcoma, Distant failure, Local tumor control, Proton therapy, Radiation induced toxicity, Skull-base tumor
Référence
Radiother Oncol. 2018 Jul 16;: